Setback for Johnson & Johnson! Judge rejects third settlement attempt through bankruptcy in talc case!
Reading Time: 4 minutes
The pharmaceutical and biotechnology company Johnson & Johnson (JNJ) has been trying to resolve its legal issues related to talc products for several years. The current third attempt has once again failed, as a Texas bankruptcy judge has halted the potential settlement. The health giant has stated that it will not appeal the ruling. Additionally, it was announced that the planned acquisition of Intra-Cellular Therapies is scheduled for April 2, 2025, and not as previously and incorrectly reported as already completed. The stock plummeted by...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
